Outcomes Of The TOURMALINE-MM3 Study
Ravi Vij, MD Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Outcomes Of The TOURMALINE-MM3 Study. At The 60th ASH...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
The Role Of Molecular Testing In AML
James McCloskey, MD Interim Chief, Division of Leukemia, Hackensack University Medical Center, John Theurer Cancer Center, discusses The Role Of Molecular Testing In AML. At The 60th ASH Annual Meeti...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Using CAR-T Therapies In Leukemia & Lymphoma
Frederick Locke, MD Program Co-Leader, Immunology Moffitt Cancer Center Discusses Using CAR-T Therapies In Leukemia & Lymphoma. At The 60th ASH Annual Meeting on Dec 1, 2018.
Author: obr
Added: 01/12/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 12, 2019 Category: Cancer & Oncology Source Type: podcasts
Dr. Vij Shares Data Regarding His Clinical Trial Presented At ASH 2018
Ravi Vij, MD Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine Discusses Data Regarding His Clinical Trial Presented At ASH 201...
Author: obr
Added: 01/11/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 12, 2019 Category: Cancer & Oncology Source Type: podcasts
Application Of The FLT3 Test In Newly Diagnosed AML Patients
James McCloskey, MD Interim Chief, Division of Leukemia, Hackensack University Medical Center, John Theurer Cancer Center Discusses Application Of The FLT3 Test In Newly Diagnosed AML Patients At The ...
Author: obr
Added: 01/11/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2019 Category: Cancer & Oncology Source Type: podcasts
Leukemia-Initiating Metabolic Switch & How Vascular Integrity Impacts It
Jason Butler, PhD Associate Scientist, Regenerative Medicine and Associate Professor, Center for Discovery and Innovation, Hackensack University, Discusses Leukemia-Initiating Metabolic Switch & How V...
Author: obr
Added: 01/11/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2019 Category: Cancer & Oncology Source Type: podcasts
LEAP Consortium In Pediatric Acute Leukemia And Their Efforts
Yana Pikman, M.D. Instructor in Pediatrics, Dana Farber Cancer Institute, Boston Childrens Hospital, Discusses LEAP Consortium In Pediatric Acute Leukemia And Their Efforts At The 60th ASH Annual Mee...
Author: obr
Added: 01/11/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2019 Category: Cancer & Oncology Source Type: podcasts
Treating CML & Myelofibrosis Patients
Ellen Ritchie, M.D. assistant professor of medicine and a member of the Leukemia Program at the Weill Cornell Medical College Discusses Treating CML & Myelofibrosis Patients at Lymphoma & Myeloma on O...
Author: imedex
Added: 12/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 31, 2018 Category: Cancer & Oncology Source Type: podcasts
Interferon As An Option
Ellen Ritchie, M.D. assistant professor of medicine and a member of the Leukemia Program at the Weill Cornell Medical College Discusses Interferon As An Option at Lymphoma & Myeloma on October 18, 201...
Author: imedex
Added: 12/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 31, 2018 Category: Cancer & Oncology Source Type: podcasts
FDA Drug Safety Podcast: FDA warns that symptoms of a serious condition affecting the blood cells are not being recognized with the leukemia medicine Idhifa (enasidenib)
On November 29, 2018 FDA is warning that signs and symptoms of a life-threatening side effect called differentiation syndrome are not being recognized in patients receiving the acute myeloid leukemia medicine Idhifa, active ingredient enasidenib. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 6, 2018 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Key Insights in Chronic Lymphocytic Leukemia: from Lymphoma & Myeloma 2018
Earn CME: <a target='_blank' href='https://naccme.com/program/7308'>https://naccme.com/program/...</a><br /><br />In this Key Insights activity, Drs. Morton Coleman and Richard R. Furman discuss CLL-related highlights from Lymphoma & Myeloma 2018: An International Con...
Author: imedex
Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts
Plasma cell leukemia and extramedullary disease in multiple myeloma
What is the current treatment landscape for plasma cell leukemia and extramedullary disease in multiple myeloma (MM)? We spoke to Niels van de Donk, MD, PhD, of VU University Medical Center, Amsterdam...
Author: VJHemOnc
Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts
CD47-targeting antibody: targeting the source of non-Hodgkin lymphoma
CD47 has been found to be present on leukemic stem cells, but not on normal hematopoietic stem cells, offering an opportunity to target the source of the disease. Here, Irving Weissman, MD, of the Sta...
Author: VJHemOnc
Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts
An exciting development: FLT3 inhibitors as a combination therapy?
While novel FLT3 inhibitors have been, or will be, approved for use as single agents in the treatment of acute myeloid leukemia (AML). Here, Alexander Perl, MD, of the University of Pennsylvania, Phil...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Is venetoclax a game changer in AML therapy?
Venetoclax in combination with low intensity chemotherapy for acute myeloid leukemia (AML) in the frontline setting, which although currently under evaluation by the FDA, has shown impressive results....
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
